High Priority Alert

Masking and Visitation Changes: Due to high rates of respiratory illnesses in our community, we’ve made changes to our masking and visitation guidelines. Learn more.

Search Search

Current Research

Help us answer questions about childhood health and illness, and help other children in the future. Learn more.

RADIANT Study

RADIANT is a nationwide network of researchers studying rare and atypical diabetes. Diabetes is a disease that is characterized by high levels of sugar in the blood and urine. There are many different kinds of diabetes. This research study is aimed at identifying atypical forms of diabetes that are unlike type 1 and type 2 diabetes. You may be eligible to take part in this research study if we think you may have an atypical form of diabetes. This study could provide information about atypical forms of diabetes that may lead to better diagnosis and treatment.

RADIANT has three stages. Some parts of the study would be done remotely, and others might be done in person at Seattle Children’s. With your consent, we would collect blood samples from you for laboratory and genetic testing. We would ask you to complete questionnaires, and we would also collect information from your medical records.

If you are interested in participating in RADIANT, please contact the Seattle Children’s Diabetes Research Team at diabetesresearch@seattlechildrens.org or 206-987-2540.

Juvenile Diabetes Research Foundation (JDRF) Study

The main goal for this study is to learn more about what causes autoimmune disease, especially diabetes. To help answer this question we will gather information about:

  • History of the disease course
  • Family history of diabetes and other autoimmune diseases
  • Specific proteins, cells and genes that reflect the body's immune system activity
  • Measures of the body's insulin production

With this information we hope to identify markers that would allow us to treat diabetes in youth effectively. Participants will be compensated for their time with a $50 gift card. This visit can only take place at Seattle Children's.

TrialNet Type 1 Diabetes Risk Screening

TrialNet is a global clinical research network at the forefront of type 1 diabetes (T1D) research. TrialNet offers risk screening for relatives of people with T1D and innovative clinical studies testing ways to slow down and prevent disease progression. Offered at no cost to people with relatives with T1D, this unique screening can identify the early stages of T1D years before any symptoms appear. Individuals found to be at increased risk of type 1 diabetes can be closely monitored, or they may be eligible to join a prevention study exploring ways to prevent it. 

Family members can visit www.TrialNet.org to sign up for screening, or contact Benaroya Research Institute in Seattle at 800-888-4187 or diabetes@benaroyaresearch.org.

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.